BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15287022)

  • 1. Mutational activation of the MAP3K8 protooncogene in lung cancer.
    Clark AM; Reynolds SH; Anderson M; Wiest JS
    Genes Chromosomes Cancer; 2004 Oct; 41(2):99-108. PubMed ID: 15287022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations.
    Lehmann BD; Shaver TM; Johnson DB; Li Z; Gonzalez-Ericsson PI; Sánchez V; Shyr Y; Sanders ME; Pietenpol JA
    Mol Cancer Res; 2019 Sep; 17(9):1842-1853. PubMed ID: 31186280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
    Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
    J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of activating mutations of the RAF1 protooncogene in human lung cancer.
    Miwa W; Yasuda J; Yashima K; Makino R; Sekiya T
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):705-9. PubMed ID: 7888083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
    Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
    Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells.
    Kannan Y; Li Y; Coomes SM; Okoye IS; Pelly VS; Sriskantharajah S; Gückel E; Webb L; Czieso S; Nikolov N; MacDonald AS; Ley SC; Wilson MS
    J Allergy Clin Immunol; 2017 Feb; 139(2):655-666.e7. PubMed ID: 27484038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.
    Marks JL; Gong Y; Chitale D; Golas B; McLellan MD; Kasai Y; Ding L; Mardis ER; Wilson RK; Solit D; Levine R; Michel K; Thomas RK; Rusch VW; Ladanyi M; Pao W
    Cancer Res; 2008 Jul; 68(14):5524-8. PubMed ID: 18632602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer.
    Xia L; Gao J; Ma K; Lin H; Chen Y; Luo Q; Lian J
    Pathol Res Pract; 2021 Aug; 224():153493. PubMed ID: 34098198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
    Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
    Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation.
    Aoki M; Hamada F; Sugimoto T; Sumida S; Akiyama T; Toyoshima K
    J Biol Chem; 1993 Oct; 268(30):22723-32. PubMed ID: 8226782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of squamous cell carcinoma after MAP3K8 overexpression in murine salivry gland epithelial cells.
    Lee JH; Jeong JH; Kim TH; Kim SY; Kim KE; Seong JK; Lee SH
    Head Neck; 2019 Apr; 41(4):924-929. PubMed ID: 30723988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas.
    Gruosso T; Garnier C; Abelanet S; Kieffer Y; Lemesre V; Bellanger D; Bieche I; Marangoni E; Sastre-Garau X; Mieulet V; Mechta-Grigoriou F
    Nat Commun; 2015 Oct; 6():8583. PubMed ID: 26456302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
    Wei R; Yang Q; Han B; Li Y; Yao K; Yang X; Chen Z; Yang S; Zhou J; Li M; Yu H; Yu M; Cui Q
    Oncotarget; 2017 Mar; 8(10):16633-16641. PubMed ID: 28186962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
    Luciano BS; Hsu S; Channavajhala PL; Lin LL; Cuozzo JW
    J Biol Chem; 2004 Dec; 279(50):52117-23. PubMed ID: 15466476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
    Newman S; Fan L; Pribnow A; Silkov A; Rice SV; Lee S; Shao Y; Shaner B; Mulder H; Nakitandwe J; Shurtleff S; Azzato EM; Wu G; Zhou X; Barnhill R; Easton J; Nichols KE; Ellison DW; Downing JR; Pappo A; Potter PM; Zhang J; Bahrami A
    Nat Med; 2019 Apr; 25(4):597-602. PubMed ID: 30833747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.